Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium

NCT01783314 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT01783314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01783314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2010
Completion date
December 31, 2014
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic fibrosis